White paper: The Cardiovascular Benefits of the Virta Treatment
Learn how the Virta Treatment not only delivers type 2 diabetes reversal rates of 60% at one year, but also significantly improves cardiovascular disease risk factors, including blood pressure, inflammation, and obesity.
Download the white paper here.
DOWNLOAD WHITE PAPER
OF INSULIN USERS REDUCED
OR ELIMINATED USAGE
AVERAGE WEIGHT LOSS
Our peer reviewed clinical trial results are causing organizations to rethink their approach to diabetes. At 1 year, most patients see sustained improvements in blood sugar control, medication reduction and elimination, clinically significant weight loss, improved triglycerides, and lowered inflammation.
Hallberg SJ, McKenzie AL, Williams P, et al. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018. DOI: 10.1007/s13300-018-0373-9
If you are a health plan or benefits leader, a physician, or a potential patient, let's discuss how Virta can help you.
Interested in Learning More?